The Clinical Observation Of Chloasma (the Type Of Qi Stagnancy In Liver)Treated By The Modification Prescription Of Chai Hu Shu Gan San

Objective:To observe the clinical efficacy of modification prescription of ChaiHuShuGanSan on Chloasma (the type of Qi Stagnancy in Live).Methods:The cases of this study are typical Chloasma patients who are from the First Affiliated Hospital of Heilongjiang University of Chinese Medicine from February2013to February2014for medical treatment. They are diagnosed liver-qi stagnation syndrome according to Chinese Medicine standard. Patients are numbered consecutively and randomly divided into the treating group and the control group. Each group has36cases. The treating group is treated with ChaiHuShuGanSan and take the medicine one dose in twice a day. The control group is given ShuGanKeLi,3g once a time, twice a day. Both groups are observed treatment effect in the twenty-eight days,fifty-six days and eighty-four days later.Results:After the treatment, The total effective rate is88.2%in the control group, the total effective rate is64.7%in the control group, there is a significant difference between the two groups (P<0.05). Treatment group and the control group lesions total score, total score decreased index, an area integral, integral color has a significant difference (P<0.05).Conclusion:ChaiHuShuGanSan can improve the symptoms of Chloasma (the type of Qi Stagnancy in Live) significantly. ChaiHuShuGanSan is superior to the control group in improving the patients with Chloasma (the type of Qi Stagnancy in Live) skin damage scale and the area integral.